Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
Baroda BNP Paribas Health and Wellness Fund Direct Growth
Baroda BNP Paribas Mutual Fund
62steady
Latest NAV
₹10.9952
as of 07 Aug 2026
AUM
—
Expense ratio
—
Inception
14 May 2026
FundScore
62/100steady
Rank #381 of 1007 · top 38%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
4.41%
3M
9.72%
6M
18.32%
1Y
12.78%
3Y CAGR
—
5Y CAGR
—
Since incep.
8.87%
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap31.8%
Mid cap39.1%
Small cap29.1%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Jun 2026.
Sun Pharmaceutical Industries Limited
equity
7.58%
Lupin Limited
equity
6.56%
Laurus Labs Limited
equity
6.31%
IPCA Laboratories Limited
equity
5.80%
Torrent Pharmaceuticals Limited
equity
5.43%
Divi's Laboratories Limited
equity
5.35%
Apollo Hospitals Enterprise Limited
equity
4.87%
JB Chemicals & Pharmaceuticals Limited
equity
4.57%
Fortis Healthcare Limited
equity
4.32%
AstraZeneca Pharma India Limited
equity
3.87%
Emcure Pharmaceuticals Limited
equity
3.60%
SBI Life Insurance Company Limited
equity
3.19%
Glenmark Pharmaceuticals Limited
equity
3.19%
Mankind Pharma Limited
equity
2.99%
Aurobindo Pharma Limited
equity
2.85%
Dr. Lal Path Labs Limited
equity
2.53%
Zydus Lifesciences Limited
equity
2.51%
Aster DM Healthcare Limited
equity
2.41%
Acutaas Chemicals Limited
equity
2.30%
Max Financial Services Limited
equity
2.25%
Abbott India Limited
equity
2.07%
Ajanta Pharma Limited
equity
1.95%
Nephrocare Health Services Ltd
equity
1.84%
Concord Biotech Limited
equity
1.74%
Inventurus Knowledge Solutions Limited
equity
1.52%
Metropolis Healthcare Limited
equity
1.27%
Dr. Reddy's Laboratories Limited
equity
1.23%
MedPlus Health Services Limited
equity
1.17%
Gland Pharma Limited
equity
1.13%
Cipla Limited
equity
1.06%